Levodropropizine
Code | Size | Price |
---|
TAR-T0217-1g | 1g | £104.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0217-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Levodropropizine is a histamine receptor inhibitor. It is used as an effective and very well tolerated peripheral antitussive drug.
CAS:
99291-25-5
Formula:
C13H20N2O2
Molecular Weight:
236.315
Pathway:
Neuroscience; Immunology/Inflammation; GPCR/G Protein
Purity:
0.9993
SMILES:
OC[C@@H](O)CN1CCN(CC1)c1ccccc1
Target:
5-HT Receptor; Histamine Receptor
References
1. Melillo G, et al. Arzneimittelforschung, 1988, 38(8), 1144-1150.
2. Shams H, et al. Br J Pharmacol, 1996, 117(5), 853-858.
3. Malandrino S, et al. Arzneimittelforschung, 1988 , 38(8), 1141-1143.
4. Lavezzo A, et al. Pulm Pharmacol, 1992, 5(2), 143-147.
5. Yamawaki I, et al. Eur J Pharmacol, 1993, 243(1), 1-6.
6. Zanasi A, et al. Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med. 2015 May 31;10(1):19.